TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
魏國珍Wei, Kuo-Chen
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
-
kuochenwei@cgmh.org.tw
Publication
11Publications
11
Wei KC*, Hsu PW, Tsai HC, Lin YJ, Chen KT, Toh CH, Huang HL, Jung SM, Tseng CK, Ke YX. Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study. Scientific Reports. 2021 Dec; 11: 24067.
1
2
